Triphasic oral contraception: Metabolic effects in normal women and those with previous gestational diabetes
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The effect of a low-dose triphasic oral contraceptive (ethinyl estradiol and levonorgestrel) on glucose tolerance, plasma insulin and glucagon responses to glucose, fasting plasma cortisol, triglycerides, free fatty acids, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and very--low-density lipoprotein cholesterol was investigated in 16 women with previous gestational diabetes and in 19 normal women. Investigations were performed prior to the hormonal intake and after treatment for 2 and 6 months. Before treatment, the women with previous gestational diabetes had significantly elevated fasting glucose (p less than 0.05) and impaired glucose tolerance (p less than 0.05) when compared to those of the healthy control subjects. The glucose, insulin, and glucagon responses to oral glucose remained unchanged during the treatment period. Plasma cortisol increased in both groups (p less than 0.05) whereas plasma triglycerides increased in the control subjects only (p less than 0.05). Plasma free fatty acids, lipoproteins, and high-density lipoprotein cholesterol/total cholesterol ratio remained unchanged in both groups. The results suggest that a low-dose triphasic oral contraceptive (ethinyl estradiol and levonorgestrel) is suitable as contraception even in women with a previous deterioration of glucose tolerance during pregnancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Combined oral contraceptive use by women with a history of gestational diabetes does not increase the risk of later developing type 2 diabetes (220–223).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [220]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
A simple and ultrasensitive method for determination of free fatty acid by radiochemical assay
Ho, R. J., & Meng, H. C. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90284-x · Cited by 516
ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENT
Böttiger, L. E., Boman, G., Eklund, G., & Westerholm, B. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91550-0 · Cited by 394
Munck, A. (1971) · Perspectives in Biology and Medicine · doi:10.1353/pbm.1971.0002 · Cited by 340
Addison, G. M. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91681-x · Cited by 336
SOME EFFECTS OF ORAL CONTRACEPTIVES ON SERUM-LIPID AND LIPOPROTEIN LEVELS
Wynn, V., Doar, J. W. H., & Mills, G. L. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92979-5 · Cited by 179
ALTERED PLASMA LIPID AND LIPOPROTEIN LEVELS ASSOCIATED WITH ORAL CONTRACEPTIVE AND ŒSTROGEN USE
Wallace, R., Hoover, J., Barrett-Connor, E., Rifkind, B., Hunninghake, D., Mackenthun, A., & Heiss, G. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90001-1 · Cited by 160
GLUCOSE METABOLISM DURING AND AFTER PREGNANCY IN NORMAL AND GESTATIONAL DIABETIC WOMEN
Kühl, C. (1975) · Acta Endocrinologica · doi:10.1530/acta.0.0790709 · Cited by 151
Research works printed but not linked: 2
- Waine, 1963, Metabolic effects of Enovid in rheumatoid patients, Arthritis Rheum, 6, 796
- Dolhofer, 1976, Experience with the glucose-dehydrogenase-UV method for the determination of blood glucose, J Clin Chem Clin Biochem, 14, 415
Cited by
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
Curtis, K. M., Tepper, N. K., Jatlaoui, T. C., Berry-Bibee, E., Horton, L. G., Zapata, L. B., Simmons, K. B., Pagano, H. P., Jamieson, D. J., & Whiteman, M. K. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6503a1 · Cited by 1,456
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
Nguyen, A. T., Curtis, K. M., Tepper, N. K., Kortsmit, K., Brittain, A. W., Snyder, E. M., Cohen, M. A., Zapata, L. B., Whiteman, M. K., Contributors, et al. (2024) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7304a1 · Cited by 241
Kjos, S. L. (1998) · JAMA · doi:10.1001/jama.280.6.533 · Cited by 174
Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.
Korytkowski, M. T., Mokan, M., Horwitz, M. J., & Berga, S. L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593446 · Cited by 140
Metadata
- Authors
- Skouby, S. O., Kühl, C., Mølsted-Pedersen, L., Petersen, K., & Christensen, M. S.
- Affiliations
- Herlev Hospital (DK)
- Corresponding author
- Skouby, Sven O.
- ORCID
- Skouby, Sven O.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 1985-11
- Volume
- 153
- Issue
- 5
- Pages
- 495-500
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W1994495403
- Cited by
- 67
- References
- 27
- Citations by year
- 2026: 1 · 2024: 2 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 4
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- American Journal of Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- triphasic oral contraceptives, ethinyl estradiol, levonorgestrel, gestational diabetes mellitus, glucose tolerance, insulin response, glucagon response, plasma cortisol, triglycerides, free fatty acids, lipoproteins, cholesterol
- MeSH terms
- Adult, Blood Glucose, Contraceptives, Oral, Combined, Drug Administration Schedule, Ethinyl Estradiol, Female, Glucagon, Glucose Tolerance Test, Humans, Hydrocortisone, Insulin, Lipids, Norgestrel, Pregnancy, Pregnancy in Diabetics, Levonorgestrel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triphasic oral contraception: Metabolic effects in normal women and those with previous gestational diabetes. https://app.cochat.ai/papers/10.1016/0002-9378(85)90460-0
- The paper
- Skouby, S. O., Kühl, C., Mølsted-Pedersen, L., Petersen, K., & Christensen, M. S. (1985). Triphasic oral contraception: Metabolic effects in normal women and those with previous gestational diabetes. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/0002-9378(85)90460-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.